KINGDON CAPITAL MANAGEMENT, L.L.C.
Position in TVTX — Travere Therapeutics, Inc.
CIK 1000097
NEW YORK, NY
Position in TVTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
New position
Shares Held
0
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Derivatives in TVTX
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$5,942,000
PutShares
200,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026KINGDON CAPITAL MANAGEMENT, L.L.C. holds $112,338,858 across 9 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SNDX |
Syndax Pharmaceuticals Inc
|
2,500,000 | $54,650,000 | |
| 2 | OLMA |
Olema Pharmaceuticals, Inc.
|
1,200,000 | $15,012,000 | |
| 3 | CYTK |
Cytokinetics Inc
|
157,100 | $13,383,349 | |
| 4 | ZVRA |
Zevra Therapeutics, Inc.
|
775,000 | $11,113,500 | |
| 5 | ALDX |
Aldeyra Therapeutics, Inc.
|
2,652,315 | $5,649,430 | |
| 6 | IVA |
Inventiva S.A.
|
1,270,000 | $4,800,600 | |
| 7 | ELDN |
Eledon Pharmaceuticals, Inc.
|
1,039,275 | $4,094,743 | |
| 8 | CMPX |
Compass Therapeutics, Inc.
|
1,400,000 | $3,066,000 |
All Filings in TVTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,942,000 | 200,000 | Put | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||